Scholarship

Research and Scholarship Expectations

All fellows are expected to actively engage in scholarly activities. These activities can be in basic research, clinical research, health outcomes research, and/or educational research. Essential to success is providing the tools necessary to foster the fellows’ intellectual development as investigators. These tools are provided through participation in VCUHS graduate medical education research series, which is conducted at the start of the academic year and is mandatory for all second year fellows. Fellows receive three research months over the period of their training. Fellows with a strong interest in research can get additional time. 

As a sign of our commitment to the scholarly efforts of the fellows, the Department of Internal Medicine has designated funding which is set aside specifically to offset the travel cost for fellows who are presenting their work at regional, national, and international scientific and academic meetings. The division is similarly committed to assisting with costs associated with presenting and publishing scholarly efforts. The commitment to our fellows is evident by the fact that our department chair, Dr. John Nestler, an NIH-funded investigator himself, personally meets with all fellows in advance of presenting at national and international meetings to offer additional mentorship and guidance. At VCU, we honor your education and professional growth as our greatest achievement and are proud to send our residents and fellows as our ambassadors. 

Fellows’ Scholarly Activities


Acharya, Chathur

Abstracts and Presentations

  1. Acharya, C., B White, M., Fagan, A., Sterling, R., Stravitz, R., Puri, P., Fuchs, M., Luketic, V., Sanyal, A., Wade, J., John, B., Gilles, H., Heuman, D., Tinsley, F., Matherly, S., Lee, H., Siddiqui, M.S., Bajaj, J. Cognitive And Physical Frailty Are Linked And Demonstrate Sustained Improvement After Liver Transplant, DDW. May 2019. Accepted.

Publications

  1. Bajaj, J., Fagan, A., White, M., Wade, J., Hylemon, P., Heuman, D., Fuchs, M., John, B., Acharya, C., Sikaroodi, M., Gillevet, P. Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy. Am J Gastroenterol. January 2019. Published.

  2. Bajaj, J., Matin, P., White, M., Fagan, A., Golob Deeb, J., Acharya, C., Dalmet, S., Sikaroodi, M., Gillevet, P., Sahingur, S. Periodontal therapy favorably modulates the oral-gut-hepatic axis in cirrhosis. Am J Physiol Gastrointest Liver Physiol, November 2018. Published.

  3. Acharya, C., Bajaj, J. Altered Microbiome In Patients With Cirrhosis and Complications. Clin Gastroenterol Hepatol, January 2019 17(2): 307-321. Published.

  4. Bajaj, J., Acharya, C., Fagan, A., White, M., Gavis, E., Heuman, D., Hylemon, P., Fuchs, M., Puri, P.,Schubert, M., Sanyal, A., Sterling, R., Stravitz, R., Siddiqui, M.S., Luketic, V., Lee, H., Sikaroodi, M., Gillevet, P. Proton Pump Inhibitor Initiation and Withdrawal Affects Gut Microbiota and Readmission Risk in Cirrhosis. Am Gastroenterol, August 2018 113(8):1177-1186. Published.

  5. Rice, J., Dodge, J., Bambha, K., Bajaj, J., Reddy, K., Gralla, J., Ganapathy, D., Mitrani, R., Reuter, B.,Palecki, J., Acharya, C., Shaw, J., Burton, J., Biggins, S. Neutrophil-to-Lymphocyte Ratio Associates Independently With Mortality in Hospitalized Patients With Cirrhosis. Clin Gastroenterol Hepatol, November 2018 16(11): 1786-1791. Published.

Banini, Bubu

Abstracts and Presentations

  1. Oseini A, Toldo S, Seneshaw M, Kumar D, Santhekadur PK, Min H, Mezzaroma E, Bedossa P, Mauro G, Quaini F, Frati C, Falco A, Koduru S, Banini BA, Mirshahi F, Abbate A, Rider O, Siddiqui M, Sanyal AJ. The Physiological, Pathological and Molecular Basis of Nonalcoholic Steatohepatitis Associated Cardiomyopathy. American Association for Study of Liver Diseases Annual Meeting. October 2017. Poster Presentation.

  2. Banini BA, Cazanave S, Min H, Kumar DP, Santhekadur P, Wang L, Guan H, Seneshaw M, Bedossa P, Oseini A, Mirshahi F, Alonso C, Koduru SV, Sanyal AJ. Acceleration of NASH in a mouse model provides novel insights on the mechanisms by which I148M PNPLA3 drives steatohepatitis. International Liver Congress, European Association for Study of the Liver. April 2018; Paris, France. Oral Presentation

  3. Banini BA, Cazanave S, Min H, Kumar DP, Santhekadur P, Wang L, Guan H, Seneshaw M, Bedossa P, Oseini A, Mirshahi F, Alonso C, Koduru SV, Sanyal AJ. NASH acceleration in DIAMOND mice provides insights into the mechanisms by which I148M PNPLA3 drives steatohepatitis. Ed Moore Research Day. April 2018. Oral Presentation.

  4. Banini, B., Liang, T., Chalasani, N., Liu, W., Liu, Z., Le, P., Mirshahi, F., Shah, V., Sanyal, A. Haptoglobin 2 Allele Is Associated With Increased Risk And Severity Of Alcoholic Hepatitis. Oral Presentation. Digestive Diseases Week. May 2019.

  5. Banini, B., Issa, D., Seneshaw, M., Siddiqui, M., Oseini, A., Mirshahi, F., Dessie, S., Puri, P., Aneni, E., Blaha, M., Budoff, M., Mahmoud, S., Moyses, N., Khurram, J., Sanyal, A. Non-Alcoholic Fatty Liver Disease Is Associated With Qtc Lengthening In The General Population. Poster Presentation. European Association for Study of the Liver. April 2019.

Awards

  1. Banini BA. EASL Young Investigator Bursary Award. European Association for Study of the Liver. April 2018.

Publications

  1. Banini BA, Sanyal AJ. Vitamin E in fatty liver disease. Vitamin E in Human Health.

  2. Banini BA, Sanyal AJ. Coagulopathy: pathophysiology, evaluation & treatment. Liver Anesthesiology and Critical Care Medicine, 2nd Edition. May 2018.

  3. Cazanave S, Podtelezhnikov A, Jensen K, Seneshaw M, Kumar DP, Min HK, Santhekadur PK, Banini BA, Mauro AG, M Oseini A, Vincent R, Tanis KQ, Webber AL, Wang L, Bedossa P, Mirshahi F, Sanyal AJ. The Transcriptomic Signature of Disease Development and Progression of Nonalcoholic Fatty Liver Disease. Sci Rep. 2017;1(7).

  4. Banini BA, Cazanave SC, Yates KP, Asgharpour A, Vincent R, Mirshahi F, Le P, Contos MJ, Tonascia J, Chalasani NP, Kowdley KV, McCullough AJ, Behling CA, Schwimmer JB, Lavine JE, Sanyal AJ for the NASH CRN. Haptoglobin 2 allele is associated with histological response to vitamin E in subjects with nonalcoholic steatohepatitis. Liver International. Submitted.

  5. Banini BA, Mutha PR, Shah TU. A sentinel problem: migrated aorto-femoral graft identified during upper endoscopy. Submitted.

Chhatrala, Ravi

Abstracts and Presentations

  1. Chhatrala R, Siddiqui MB, Stravitz R, Driscoll C, Sanyal A, Sargeant C, Riyaz F, Luketic V, Sterling R, Matherly S, Puri P, Fisher M. Pro-Atherogenic Lipoproteins and Metabolic Biomarkers Drive Derum Cardiovascular Risk in Liver Transplant Recipients. Poster Presentation, American Association for the Study of Liver Disease Annual Meeting. November 2014, Boston MA.

  2. Chhatrala R, Siddiqui MB, Stravitz R, Driscoll C, Sanyal A, Sargeant C, Luketic V, Sharma A, Sterling R, Matherly S, Puri P. Evolution of the Serum Atherogenic Risk in Liver Transplant Recipients; Role of Lipoproteins, Metabolic and Inflammatory Markers. Poster Presntation, ACG Annual Scientific Meeting. October 2014, Philadelphia PA.

Publications

  1. Chhatrala R, Siddiqui MB, Stravitz R, Driscoll C, Sanyal A, Sargeant C, Luketic V, Sharma A, Sterling R, Matherly S, Puri P. Evolution of the Serum Atherogenic Risk in Liver Transplant Recipients; Role of Lipoproteins, Metabolic and Inflammatory Markers. Liver Transplant J. 5(21);2015;623-30.

Davis, Brian

Abstracts and Presentations

  1. Davis BC, Bajaj JS. Effects of Alcohol on the Brain in Cirrhosis: Beyond Hepatic Encephalopathy. Alcohol Clin Exp Res. 2018 Apr;42(4):660-667

  2. Davis BC, Bajaj JS. The Human Gut Microbiome in Liver Diseases. Semin Liver Dis. 2017 May;37(2):128-140.

  3. Patidar, K., Kang, L., Davis, B., Taylor, S., Stravitz, R. Admission Factor VIII/V Ratio and Factor V Are Independent Predictors of Poor Prognosis in Patients with Acute Liver Failure. Poster Presentation. The Liver Meeting 2018.

  4. Davis, B., Acharya, C., Sahingur, S., White, M., Bajaj, J. Oro‐Dental Health Disparities in Patients with Cirrhosis. Poster Presentation. The Liver Meeting 2018.

  5. Peeraphatdit, T., Kamath, P., Davis, B., Desai, V., Liangpunsakul, S., Sanyal, A., Chalasani, N., Katz, B., Shah, V., Simonetto, D. Early Alcohol Rehabilitation May Prevent Readmission, Alcohol Relapse and Death after Alcoholic Hepatitis Admission. Poster Presentation. The Liver Meeting 2018. Accepted.

Publications

  1. 1. Peeraphatdit, T., Kamath, P., Karpyak, V., Davis, B., Desai, V., Liangpunsakul, S., Sanyal, A., Chalasani, N.,

  2. 2. Shah, V., Simonetto, D. Alcohol Rehabilitation Within 30 Days of Hospital Discharge is Associated With Reduced Readmission, Relapse, and Death in Patients with Alcoholic Hepatitis. Clinical Gastroenterology and Hepatology, 2019.

Dharel, Narayan

Publications

  1. Dharel N, Sterling, RK. Treatment of Hepatitis C, Then, Now and Tomorrow. Evid Based Med. 2015 Feb;20(1):23.

  2. Sterling RK, Dharel N The Hot HCV Question: Treat Everyone Now or Only Those with Advanced Fibrosis? American Gastroenterology Association Perspectives. February 2015.

  3. Dharel N, Sterling RK. Hepatitis B Virus-HIV Coinfection: Forgotten but Not Gone. Gastroenterology & Hepatology. 10(12);2014;781-88

  4. Acharya C, Dharel N, Sterling RK. Chronic Liver Disease in the Human Immunodeficiency Virus Patient. Clin Liver Dis. 19 (1);2015;1-22.

  5. Dharel N, Fuchs M. Non-alcoholic Fatty Liver Disease. Review. Scientific American Gastroenterology. 2015. (In Press)

  6. Dharel N, Kapoor A, Sanyal AJ. Endoscopic Diagnosis and Management of Variceal Upper Gastrointestinal Bleeding. Gastrointestinal Endoscopy Clinics of North America. 2015. (In Press)

  7. Dharel N, Bajaj JS. Definition and Nomenclature of Hepatic Encephalopathy. Journal of Clinical and Experimental Hepatology. 5(1);2015;S37-41.

  8. Dharel N, Bajaj JS. Antibiotic Prophylaxis in Acute Liver Failure: Friend or Foe?. Clin Gastroentrol Hepatol J. 12(11);2014 Nov;1950-2.

Henry, George

Abstracts and Presentations

  1. Solomon SS, Mota M, Gandhi K, Hillyard JC, Henry G, Rodriguez VA, Sima A, Vachhani RK. Endoscopic Outcomes Are Poorly Predicated by Ferritin, Transferrin Saturation and Mean Corpuscular Volume in Patients Referred for Anemia Evaluation. ACG. 2018. Poster Presentation.

Issa, Danna

Abstracts and Presentations

  1. Issa D, Puri P, Dessie S, Kowlgi NG, Siddiqui MS, Sanyal AJ. Severity of Hepatic Steatosis Drives QTC Prolongation in Non-Cirrhotic Patients with Nonalcoholic Steatohepatitis. Digestive Disease Week. 2018. Accepted.

  2. Issa D, Smallfield G, Zfass A, Shah T. Factors associated with endoscopic versus surgical management of early stage esophageal cancer. Clinical Gastroenterology and Hepatology. 2018;4.

  3. Issa D, Karvidu V, Smallfield G, BouHaidar DS. Acute Pancreatitis Secondary to the Use of Anabolic Steroids. Clinical Toxicology. 2018.

  4. Issa D, Patel V, Sanyal AJ. Future Therapies for Nonalcoholic Fatty Liver Disease. Liver International. 2018. Accepted.

  5. Doycheva I, Issa D, Watt KD, Lopez R, Rifai G, Alkhouri N. Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in Young Adults in the United States. J Clin Gastroenterol. 2018 Apr;52(4):339-346.

  6. Wattacheril J, Issa D, Sanyal AJ. Nonalcoholic Steatohepatitis (NASH) and Hepatic Fibrosis: Emerging Therapies. Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:649-662.

  7. Wattacheril J, Issa D, Sanyal AJ. Nonalcoholic Steatohepatitis (NASH) and Hepatic Fibrosis: Emerging Therapies. Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:649-662.

  8. Oseini AM, Cole BK, Issa D, Feaver RE, Sanyal AJ. Translating scientific discovery: the need for preclinical models of nonalcoholic steatohepatitis. Hepatol Int. 2018 Jan;12(1):6-16.

  9. Issa D, Shah R. Spontaneous Perforation in Eosinophilic Esophagitis: Case Presentation and Review of Literature. Diseases of the Esophagus. 2018.

  10. Issa D, Alkhouri N. Nonalcoholic fatty liver disease and hepatocellular carcinoma: new insights on presentation and natural history. HepatoBiliary Surgery and Nutrition. 2017 Dec;6(6):401-403.

  11. Issa D, Solomon S, Di Pace B, Hillyard J, Young C, Sima A, Smallfield G. Azithromycin versus Erythromycin Infusions in Upper Gastrointestinal Bleeding. American Journal of Gastroenterology. 2018. Submitted.

Kaspar, Matthew

Abstracts and Presentations

  1. Kaspar, M. Ketogenic Diet and Athletic Performance - Lose Weight, Make Gains. Oral Presentation. American Society of Parenteral and Enteral Nutrition Annual Meeting. March 2019.

Kohli, Divyanshoo

Abstracts and Presentations

  1. Kohli D. Endoscopic Management of Esophageal Foreign Bodies. Poster Presntation, ACG Annual Scientific Meeting. October 2014, Philadelphia PA.

Kumral, Dennis

Abstracts and Presentations

  1. Kumral D, Roseff S, Siddiqui MS. Routine Use of Serum Ammonia Level as Diagnostic Work Up of Patients with Hepatic Encephalopathy is Common but Does not Impact Clinical Care. Digestive Disease Week. 2018. Oral Presentation.

  2. Sterling RK, Patel V, Kumral D, Lewis S, Cherian R, Driscoll C, Genther K, Lee H, Matherly S. Treatment of HCV with DAAs in cirrhosis: Risk of early de novo hepatocellular carcinoma (HCC) and impact of HCC on SVR. AASLD. 2017. Poster Presentation.

Mangray, Sasha

Publications

  1. Mangray S, Puri P. Screening for Zinc Deficiency in Cirrhosis-When Should We Start?. Digestive Diseases and Sciences J. 2015. (Submitted)

Nabi, Eiman

Publications

  1. Nabi E, Thacker LR, Wade JB, Sterling R, Stravitz R, Fuchs M, Heuman D, Bouneva I, Sanyal A, Siddiqui M, Luketic V, White M, Monteith P, Noble N, Unser A, Bajaj J. Diagnosis of Covert Hepatic Encephalophy without Specialized Tests. Clin Gastroenterol Hepatol J. 2014.

Oseini, Abdul

Abstracts and Presentations

  1. Oseini, A., Toldo, S., Seneshaw, M., Kumar, D., Santhekadur, P., Min, K., Mezzaroma, E., Bedossa, P., Mauro, A., Quaini, F., Frati, C., Falco, A., Koduru, S., Banini, B., Mirshahi, F., Abbate, A., Rider, O., Siddiqui, M., Sanyal, A. The Pathophysiologic and Molecular Basis of Non-Alcoholic Steatohepatitis-Associated Cardiomyopathy (NAC). Poster Presentation. 2017 American Association for the Study of Liver Diseases.

  2. Banini, B., Cazanave, S., Min, H., Kumar, D., Santhekadur, P., Wang, L, Guan H., Seneshaw, M., Bedossa, P., Oseini, A., Mirshahi, F., Alonso, C., Koduru, S., Sanyal, A. Acceleration of NASH in a Mouse Model Provides Novel Insights on the Mechanisms by which I148M PNPLA3 Drives Steatohepatitis. Oral Presentation. 2018 International Liver Congress, European Association for Study of the Liver.

  3. Banini, B., Issa, D., Seneshaw, M., Siddiqui, M., Oseini, A., Mirshahi, F. Non-Alcoholic Fatty Liver Disease Is Associated With QTc Lengthening In The General Population. Oral Presentation. EASL 2019. March 2019.

  4. Hoang, S., Oseini, A., Vincent, R., Feaver, R., Cole, B., Figler, R., Lawson, M., Day, N., Taylor, J., Asgharpour, A., Mirshahi, F., Wamhoff, B., Sanyal, A. Development And Validation Of A Gene-Level Molecular Disease Activity And Fibrosis Score For Nonalcoholic Fatty Liver Disease. AASLD Annual Scientific Meeting. November 2018. Accepted.

Publications

  1. Luo, Y., Oseini, A., Gagnon, R., Charles, E., Kidik, K., Vincent, R., Collen, R., Idowu, M., Contos, M., Mirshahi, F. Daita, K., Asgharpour, A., Siddiqui, M., Jarai, G., Christian, R., Rosen, G., Sanyal, A. An Evaluation of the Collagen Fragments Related to Fibrogenesis and Fibrolysis in Non-Alcoholic Steatohepatitis. 2018 Scientific Reports. Submitted.

  2. Oseini, A., Cole, B., Issa, D., Feaver, R., Sanyal, A. Translating Scientific Discovery: The Need for Preclinical Models of Non-Alcoholic Steatohepatits. 2017 Hepatol Int 12(1): 6-16. Published.

  3. Cazanave, S., Podtelezhnikov, A., Jensen, K., Seneshaw, M., Kumar, D., Min, H., Santhekadur, P., Banini, B., Mauro, A., Oseini, A., Vincent, R., Tanis, K., Webber, A., Wang, L., Bedossa, P., Mirshahi, F., Sanyal, A. The Transcriptomic Signature of Disease Development and Progression of Nonalcoholic Fatty Liver Disease. 2017 Sci Rep 7(1): 17193. Published.

  4. Hoang, S., Oseini, A., Vincent, R., Feaver, R., Cole, B., Figler, R., Lawson, M., Day, N., Taylor, J., Asgharpour, A., Mirshahi, F., Wamhoff, B., Sanyal, A. Development And Validation Of A Gene-Level Molecular Disease Activity And Fibrosis Score For Nonalcoholic Fatty Liver Disease. Scientific Reports, 2019. Submitted.

  5. Yi Luo, Y., Oseini, A., Gagnon, R., Charles, E., Sidik, K., Vincent, R., Collen, R., Idowu, M., Contos, M., Mirshahi, F., Daita, K., Asgharpour, A., Siddiqui, M.S., Jarai, G., Christian, R., Rosen, G., Sanyal, A. An Evaluation of the Collagen Fragments Related to Fibrogenesis and Fibrolysis in Nonalcoholic Steatohepatitis. Scientific Reports, 2018 1(8): 12414. Published.

Pacana II, Tommy Y

Publications

  1. Pacana T, Sanyal A. Recent Advances in Understanding/Management of Non-Alcoholic Steatohepatitis. F1000Prime Rep. 3(7);2015;28.

  2. MinH, Mirshahi F, Verianelli A, Pacana T, Patel V, Park CG, Choi A, Lee J, Park CB, Ren S, Sanyal A. Activitation of the GP130-STAT3 Axis and It’s Potential Implications in Nonalcoholic Fatty Liver Disease. Am J Physiol Gastrointest Liver Physiol. 308(9);2015;G794-803.

Book Chapters

  1. Pacana T, Sanyal A. Role of Antioxidants in the Nonalcoholic Fatty Liver Disease Spectrum. In: Liver Metabolism and Fatty Liver Disease. CRC Press. 2015;231-246.

Patel, Samarth

Abstracts and Presentations

  1. Patel, S., Kohli, D., Savas, J., Mutha, P., Zfass, A., Shah, T. Surgery Versus Conservative Management After Endoscopic Retrograde Cholangiopancreatography for Biliary Stone Disease in High-Risk Veterans. Poster Presentation. 2017 World Congress of Gastroenterology.

  2. Lin, F., Patel, S., Pence, T., Bhati, C., Siddiqui, M. Severity of Coronary Artery Disease Affects Cardiovascular Events in Patients Undergoing Liver Transplantation. 2019 Digestive Disease Week. Accepted.

  3. Patel, S., Lin, F., Pence, T., Bhati, C., Siddiqui, M. Management of Coronary Artery Disease in Patients with Decompensated Cirrhosis. 2018 Digestive Disease Week. Accepted.

  4. Patel, S., Lin, F., Pence, T., Bhati, C., Stravitz, R., Driscoll, C., Matherly, S., Lee, H., Patel, V., Sterling, R., Sanyal, A., Luketic, V., Siddiqui, M. The Distribution of Coronary Artery Disease Among Patient with Cirrhosis Undergoing Protocoled Coronary Angiography. 2018 Digestive Disease Week. Accepted.

  5. Patel, S., Bhati, C., Siddiqui, M. Diagnostic Performance of Vibration Controlled Transient Elastography in Liver Transplant Recipients. Oral Presentation. 15th Annual VCU Resident Research Day.

Publications

  1. Patel, S., Kohli, D., Savas, J., Mutha, P., Zfass, A., Shah, T. Surgery Reduces the Risk of Complications Even in High-Risk Veterans After Endoscopic Therapy for Biliary Stone Disease. Dig Dis Sci. 2018 March; 63(3): 781-786.

  2. Patel, S. Coronary Artery Disease in Decompensated Patients Undergoing Liver Transplantation Evaluation. Liver Transpl. 2018 Apr 6. doi: 10.1002/lt.25069.

  3. Patel, S., Guzman, L., Lin, F., Pence, T., Reichman, T., John, B., Celi, F., Liptrap, E., Bhati, C., Siddiqui, M. Utilization of Aspirin and Statin in Management of Coronary Artery Disease in Patients with Cirrhosis Undergoing Liver Transplant Evaluation. Liver Transpl. 2018 Apr 6. doi: 10.1002/lt.25067.

Awards

  1. North American Conference of Gastroenterology Fellows. Awarded by the College of Gastroenterology. 2018.

Patel, Vaishali

Abstracts and Presentations

  1. Patel V, Almenara J, Mirshahi F, Sanyal A. Macrophage Phenotypes in Human NAFLD. Poster Presentation, Digestive Disease Week. May 2015, Washington DC.

Publications

  1. Min H, Mirshahi F, Verdianelli A, Pacana T, Patel V, Park C, Choi A, Lee J, Park CB, Ren S, Sanyal A. Activation of the GP130-STAT3 Axis and It’s Potential Implications in Nonalcoholic Fatty Liver Disease. Am J Physiol Gastrointest Liver Physiol. 308(9);2015;G794-803.

Patidar, Kavish

Abstracts and Presentations

  1. Patidar, K., Pace, D., Elbich, J. Strife, B., Sanyal, A., Smallfield, G. Comparison of Albumin-Bilirubin Score to Meld and Meld-Sodium Scores for the Prediction of Survival After Placement of Covered Transjugular Intrahepatic Portosytemic Shunt. Poster Presentation. 2018 Digestive Disease Week.

  2. Patidar, K., Kang, L., Bajaj, J., Carl, D., Sanyal, A. Fractional Excretion of Urea: A Simple Tool for the Differential Diagnosis of Acute Kidney Injury in Cirrhosis.

  3. Patidar, K., Kang, L., Carl, D., Sanyal, A., Bajaj, J. Fractional Exretion of Urea Predicts the Development of Acute on Chronic Liver Failure with Decompensated Cirrho. Research Presentation. AASLD’s Acute on Chronic Liver Failure Singe Topic Conference. Accepted.

  4. Patidar, K., Di Pace, B., Bhardwaj, H., Smallfield, M., Elbich, J., Strife, B., Sanyal, A., Smallfield, G. Diastolic Dysfunction Measured by Current Echocardiographic Criteria and by E/A< Does Not Predict Post-Tips Survival. Research Presentation. 2018 Digestive Disease Week.

Publications

  1. Patidar, K., Kang, L., Bajaj, J., Carl, D., Sanyal, A. Fractional Excretion of Urea: A Simple Tool for the Differential Diagnosis of Acute Kidney Injury in Cirrhosis. Hepatology. 2018 Jan 8. doi: 10.1002/hep.29772.

  2. Duarte-Rojo, A., Allampati, S., Thacker, L., Flud, C., Patidar, K. White, M., Klair, J., Heuman, D., Wade, J., Gavis, E., Bajaj, J. Diagnosis of Covert Hepatic Encephalopathy: A Multi-Center Study Testing the Utility of Single Versus Combined Testing.

  3. Patidar, K., Shaw, J., Acharya, C., Thacker, L., White, M., Ganapathy, D., Fagan, A., Gavis, E., Bajaj, J. No Association Between Quick Sequential Organ Failure Assessment and Outcomes of Patients with Cirrhosis and Infections. Clin Gastroenterol Hepatol. 2017 Nov: 15(11): 1803-1804. Published.

  4. Ganapathy, D., Lachar, J., Acharya, C., White, M., Sterling, R., Patidar, K., Ignudo, C., Bommidi, S., Bajaj, J. The Patient Buddy App Can Potentially Prevent Hepatic Encephalopathy– Related Readmissions. Liver International. 2017 Dec; 37(12): 1843-1851.

Awards

  1. Fellow Research Award. AASLD-ACLF Symposium. September 2017.

Rahimi Naini, Sohrab

Publications

  1. Rahimi Naini S, Fuchs M. Non-Alcoholic Fatty Liver Disease in Patients with Diabetes Mellitus. Expert Review Informa Healthcare. 9(5);2014;503-14.

Redman, Joseph

Publications

  1. Redman, J., Sterling, R. Treating HCV in a Captive Audience: Eradication Efforts in the Prison Microenvironment Am J Gastroenterol, November 2018 113(11):1585-1587. Published.

  2. Redman, J., Natarajan, Y., Hou, J., Wang, J., Hanif, M., Feng, H., Kramer, J., Desiderio, R., XU, H., El-Serag, H., Kanwal, F. Accurate Identification of Fatty Liver Disease in Data Warehouse Utilizing Natural Language Processing. Dig Dis Sci. 2017 62(10): 2713-2718.

  3. Redman, J., Francis, J., Marquardt, R., Papac, D., Mueller, A., Eckert, D., Welch, B., Kay, M. Pharmacokinetic and Chemical Synthesis Optimization of a Potent d-Peptide HIV Entry Inhibitor Suitable for Extended– Release Delivery. Molecular Pharmaceutics. 2018 15(3): 1169-1179.

Saraireh, Hamzeh

Abstracts and Presentations

  1. Saraireh, H. The Impact Of Opioid Epidemic Trends On Hospitalized Acute Pancreatitis Patients. Poster Presentation. Digestive Disease Week. May 2019. Accepted.

Publications

  1. Salameh, H., Sarairah, H., Rizwan, M., Kuo, Y., Anderson, K., Singal, A. Relapse Of Porphyria Cutanea Tarda After Treatment With Phlebotomy Or 4-Aminoquinoline Antimalarials: A Meta-Analysis. British Journal of Dermatology British Journal of Dermatology, December 2018, 179(6):1351-135. Published.

  2. Saraireh, H., Tayyem, O., Siddiqui, M.T., Hmoud, B., Bilal, M. Early Colonoscopy In Patients With Acute Diverticular Bleeding Is Associated With Improvement In Healthcare-Resource Utilization. Gastroenterol Report (Oxf), April 2019, 7(2):115-120. Published.

  3. Trieu, J., Bilal, M., Saraireh, H., Wang, A. Update On The Diagnosis And Management Of Gastric Intestinal Metaplasia In The USA. Digestive Diseases and Sciences, May 2019, 64(5):1079-1088. Published.

  4. Bilal, M., Tayyem, O., Saraireh, H., Chowdhry, M., Guturu, P., Abougergi, M. Upper Gastrointestinal Hemorrhage Is Associated With Poor Outcomes Among Patients With Acute Cholangitis: A Nationwide Analysis. Eur J Gastroenterol Hepatol, May 2019. Published.

Siddiqui, Mohammad

Publications

  1. Siddiqui, M., Patel, S., Bhati, C., Reichman, T. Williams, K., Driscoll, C., Liptrap, E., Rinella, M., Sterling, R., Siddiqui, MS. Range of Normal Serum Aminotransferases Levels in Liver Transplant Recipients. American Journal of Transplant.

Vincent, Robert

Abstracts and Presentations

  1. Vincent R, Cazanave S, Hae KM, Mirshahi F, Kumar DP, Ashgharpour A, Daitya K, Murthy K, Liang J. Hepatitis C Promotes Diabetes by Increasing hpatic Insulin Resistance and Pancreatic Beta Cell Failure via Suppression of Betatrophin a Novel Islet Cell Growth Factor. Poster Presentation, American Association for the Study of Liver Disease Annual Meeting. November 2014, Boston MA.

Publications

  1. Vincent R, Sanyal A. Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players. Curr Pathobiol Rep. 2014